Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

Notice of Intent to Sole Source -99194 Journal of Adolescent Health Supplement

Active
NOI99194Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Centers for Disease Control and Prevention plans to award a sole source firm-fixed-price contract to Elsevier Inc. to produce a special supplement to the Journal of Adolescent Health that will showcase key findings from the 2025 national Youth Risk Behavior Surveillance System and related trends, with a focus on critical youth health issues such as mental health, suicide, cardiovascular health, and disordered eating. The supplement will feature scientific articles authored by CDC’s Division of Adolescent and School Health scientists to communicate the significance of the survey data and advance public health understanding and action. The contract will run from September 1, 2026, through August 31, 2027, with work to be performed at Elsevier’s facilities, and the agency is proceeding under authority that permits non-competitive procurement due to the unique expertise and existing relationship with the publisher. This notice serves as an announcement of intent to award without competition, but responses from other potential providers received by 10:00 PM Eastern Time on July 30, 2026, will be considered solely to inform the government's decision on whether to open the requirement to competition. The sole point of contact for submissions is Marquetta Taylor at dwb7@cdc.gov, and while no formal solicitation is issued, any interested party may submit documentation of their capability and interest. The action falls under NAICS code 51312 and is being managed by the CDC Office of Acquisition Services under the Department of Health and Human Services, based in Atlanta, Georgia.

General Info

CDC awards Elsevier sole contract to produce youth health supplement from 2025 surveillance data.

Agency

Department Of Health And Human Services → CDC Office Of Acquisition ServicesView Agency

NAICS

51312View NAICS

Place of Performance

Atlanta, GA, 30341, USA

Set-Aside

NONE

Documents

(2)

A1.+b.+SOW.docx

DOCX

A.13.+SAP-Sole-Source-Procurement+CO+signed+15Jul2026.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

Posted

special-notice

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → CDC Office Of Acquisition Services
Contacts1 person available
OfficeATLANTA, GA, 30333, USA
Organization / Agency
Department Of Health And Human Services → CDC Office Of Acquisition Services
View Agency Profile
Office AddressATLANTA, GA, 30333, USA
Contacts
Marquetta Taylor
contact@example.gov
+1 (555) 000-0000

Full Description

Show more

Notice of Intent to Sole Source -99194 Journal of Adolescent Health Supplement


The Centers for Disease Control and Prevention intends to award a sole source firm fixed price to Elsevier INC. The purpose of this acquisition is to fund Elsevier, the publisher of Journal of Adolescent Health (JAH), to develop a special supplement of the JAH that will highlight key findings from the YRBSS, including results from the 2025 national Youth Risk Behavior Survey data, YRBS trends over time, state and local data, and with a focus on high priority topics including mental health and suicide, cardiovascular health, and disordered eating.  The objective is to produce a journal supplement that presents scientific articles written by Division of Adolescent and School Health (DASH) scientists which highlight the value of these data and provide important insights for the field on some of the most important challenges facing youth today.  This benefits CDC through facilitating dissemination of CDC-funded YRBS survey results and contributing to the national conversation on disease prevention and health promotion of youth.


 The anticipated period of performance is: 09/01/2026 - 08/31/2027


Place of Performance: Contract work will be performed at the contractor’s facilities.


This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.



This notice of intent is not a request for competitive quotations; however, all quotations/responses received prior to the date and time below will be considered by the government.  A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.  Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.  Any quotation/response should be emailed to Contract Specialist at dwb7@cdc.gov by 10:00PM (ET) on 07/30/2026.

More opportunities from Department Of Health And Human Services → CDC Office Of Acquisition Services

Same awarding agency

NAICS: 334516
New
Federal
Purchase of Evident/Olympus Stereoscope
Analytical Laboratory Instrument Manufacturing

POSTED

about 10 hours ago

DEADLINE

in 15 days
View Details
NAICS: 334516
New
Federal
Notice of Intent to Award to Sole Source - QIACube Connect SYS_FUL-1The Centers for Disease Control and Prevention intends to award a sole-source, firm-fixed-price contract to Franklin Young International, Incorporated, an authorized QIAGEN reseller, for two QIAGEN QIAcube Connect RNA/DNA Extraction Systems and their corresponding IQ/OQ services, including installation, operator training, warranty, and qualification support. This acquisition is justified under FAR 12.102(a) due to the specific technical and operational requirements of the Newborn Screening and Molecular Biology Branch, which necessitate the continued use of the QIAcube Connect platform to maintain compatibility with validated laboratory workflows and existing infrastructure. Market research confirmed no alternative products meet the government’s minimum requirements, and Franklin Young International is identified as the sole capable source through its GSA Federal Supply Schedule Contract and verified ability to deliver the exact system and services required. The procurement falls under NAICS code 334516, and all associated hardware, software, and services must be provided as a complete package to ensure full operational readiness. This notice of intent is not a competitive solicitation, but responses submitted within 15 calendar days of publication will be evaluated solely to determine if competition is feasible. Interested parties may submit capability statements electronically to the designated Contract Specialist by the deadline of August 3, 2026, to demonstrate they can meet the government’s technical and operational needs. The contract will be performed in Atlanta, Georgia, and all decisions regarding competition or sole-source award rest solely with the government based on the information received.
Analytical Laboratory Instrument Manufacturing

POSTED

2 days ago

DEADLINE

in 12 days
View Details
NAICS: 541714
New
Federal
Procurement of lateral flow (LFA) strips for the rapid HIV nucleic acid diagnostic testThe Centers for Disease Control and Prevention is seeking quotes for the procurement of lateral flow (LFA) strips to support a rapid HIV nucleic acid diagnostic test under solicitation number 75D30126Q79099. This is a combined synopsis and solicitation issued as a Request for Quote under FAR Subpart 12, governing commercial item acquisitions, and will result in a firm-fixed-price contract. The period of performance is set from August 1, 2026, through December 31, 2026, with performance taking place at the CDC’s facility located at 1600 Clifton Road, Building 17, Atlanta, Georgia. All submissions must be made in writing by 3:00 p.m. Eastern Standard Time on Friday, July 24, 2026, and no telephonic responses will be accepted. Offerors must be registered in the System for Award Management at the time of submission and are responsible for familiarizing themselves with applicable Federal Acquisition Regulation clauses, including 52.212-1 and 52.212-4. Questions must be submitted no later than close of business on Monday, July 23, 2026, to Eugene L. Gutierrez Jr. at zvm0@cdc.gov. The acquisition falls under NAICS code 541714 with no set-aside designated, and the quote format is flexible at the offeror’s discretion.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

5 days ago

DEADLINE

in about 21 hours
View Details
NAICS: 813920
New
Federal
Notice of Intent to Sole Source - Outreach, Training, and Virtual Certification Opportunities to Increase the Number of B-Readers in the United States (Virtual Course)The Centers for Disease Control and Prevention plans to award a sole source firm fixed price contract to the American College of Radiology to transition B-Reader training from in-person to a fully virtual format, delivering three complete cycles of training and certification. This includes setting up a learning management system, delivering course content, and administering secure exams to maintain and expand the national pool of qualified B Readers. The procurement is authorized under specific FAR provisions that permit non-competitive acquisition, citing 41 U.S.C. 1901 and Revolutionary FAR Overhaul 6.103-1 (SAP), with the North American Industry Classification System code 813920 identifying it as a professional organization service. The contract is categorized as supplies/services with no set-aside requirements, and the performance location is in Atlanta, Georgia. All responses to this notice of intent must be submitted via email to the designated Contract Specialist at dwb7@cdc.gov by 10:00 AM Eastern Time on August 1, 2026. This notice does not constitute a formal request for proposals, and the government retains full discretion to proceed without competition based on any responses received. The solicitation number is ACR_Virtual_Course_CDC, and the opportunity is managed by the CDC Office of Acquisition Services under the Department of Health and Human Services. Interested parties may still submit their capabilities or proposals, but these submissions will be evaluated solely to assist the government in determining whether a competitive process is warranted. The point of contact for inquiries is Marquetta Taylor, reachable by phone at 770-488-3295.
Professional Organizations

POSTED

5 days ago

DEADLINE

in 10 days
View Details
NAICS: 325414
New
Federal
(Presolicitation Notice) Intent to Sole Source - BioRad AntibodiesThe U.S. Centers for Disease Control and Prevention, through its Office of Acquisition Services under the Department of Health and Human Services, intends to award a sole source contract to Bio-Rad Laboratories for the procurement of Bio-Rad Antibodies. This action is being conducted under the simplified procedures outlined in FAR 12.201-1 and FAR 12.102, which permit non-competitive awards for commercial items when competition is not feasible. A formal solicitation does not exist, and no proposals or quotations will be accepted in response to this notice. Interested parties may submit an Expression of Interest containing detailed technical and pricing information to demonstrate the availability of a comparable source, but submission does not guarantee a competitive opportunity. All submissions must be emailed to AHR0@cdc.gov no later than 1:00 AM ET on August 1, 2026. The government retains full discretion to determine whether to proceed with a sole source award or open the requirement to competition based on the information received. The anticipated place of performance is Atlanta, Georgia, and the North American Industry Classification System code is 325414. The primary point of contact for this action is Emilio Cibula.
Biological Product (except Diagnostic) Manufacturing

POSTED

5 days ago

DEADLINE

in 9 days
View Details
NAICS: 513120
New
Federal
Publish Infant Feeding Practices Study Journal Supplement to American Academy of PediatricsThe U.S. Centers for Disease Control and Prevention, through its Office of Acquisition Services, intends to award a sole source contract to the American Academy of Pediatrics for the publication of a supplement to the Infant Feeding Practices Study Journal. This action is authorized under simplified acquisition procedures outlined in the Federal Acquisition Regulation, specifically FAR 13.106-1(b) and Subpart 12.6, and is classified under NAICS code 513120 with Product Service Code 7630. The procurement is not open to competitive bidding at this stage; no solicitation document exists, and no proposals or quotations will be accepted in response to this notice. However, interested parties may submit an Expression of Interest containing detailed technical and pricing data to demonstrate their capability to perform the work, with submissions due by 3:00 PM ET on July 31, 2026, to qty0@cdc.gov. The government retains full discretion to determine whether to proceed with a sole source award or initiate a competitive process based on the submissions received. The place of performance is Atlanta, Georgia, and inquiries should be directed to Brian Swann at the provided contact information.
Periodical Publishers

POSTED

6 days ago

DEADLINE

in 9 days
View Details
NAICS: 811210
New
Federal
Notice of Intent to Award to Sole Source -COOLED STACK SERVICE CONTRACTThe Centers for Disease Control and Prevention intends to award a sole-source, firm-fixed-price contract to Trajan Scientific Americas, Inc. for continued maintenance and technical support of existing CTC Analytics laboratory instrumentation previously acquired under Leap Technologies. The equipment, which relies on proprietary Trajan hardware and Chronos software, is critical to the operational integrity of the CDC’s Division of Laboratory Sciences, and only Trajan Scientific Americas is capable of providing compatible maintenance services that meet the agency’s minimum technical and operational requirements. The scope of work includes preventive and corrective maintenance, software and firmware updates, replacement parts, remote and on-site technical assistance, and system performance verification to ensure uninterrupted laboratory function in alignment with manufacturer specifications. This action is justified under FAR 12.102(a) as a commercial service requiring exclusive compatibility with existing proprietary systems, and no competitive solicitation is currently planned. However, the Government is inviting all interested parties to submit information demonstrating their capability to meet the requirements by July 31, 2026, at 11 AM ET, to the contract specialist Ruben Reyes at qmz3@cdc.gov. Responses will be reviewed solely to determine whether a competitive procurement is warranted, and the agency retains full discretion to proceed with the sole-source award based on the evaluation. The contract will be performed at CDC’s facility in Atlanta, Georgia, under NAICS code 811210 for Electronic and Precision Equipment Repair and Maintenance, with the procurement identified by solicitation number 97192.
Electronic and Precision Equipment Repair and Maintenance

POSTED

6 days ago

DEADLINE

in 9 days
View Details
NAICS: 325413
New
Federal
Notice of Intent to Sole Source Reagents, calibrators and controls to be used in conjunction with the VITROS 3600 Immunodiagnostic system, manufactured by QuidelOrtho Sales Company, LLCThe U.S. Centers for Disease Control and Prevention Office of Acquisition Services intends to award a sole source contract to QuidelOrtho Sales Company, LLC for the supply of reagents, calibrators, and controls compatible with the VITROS 3600 Immunodiagnostic system. This procurement is authorized under federal acquisition regulations that permit simplified procedures for commercial items and sole source actions, with the NAICS code 325413 and PSC 6550 identifying the product category. No formal solicitation exists, and responses to this notice are not proposals or quotations but expressions of interest aimed at helping the government determine whether competition is feasible. Interested parties must submit detailed technical and pricing information by 5:00 PM ET on July 31, 2026, to qty0@cdc.gov, and must ensure timely delivery. The government retains full discretion to proceed without competition based on the feedback received. The action is managed by the CDC under the Department of Health and Human Services, with the primary point of contact being Brian Swann at 678-475-4520 or bswann@cdc.gov. The contract will be performed in Atlanta, Georgia, and no set-aside provisions apply. While this notice is not a request for bids or a binding commitment, submissions will inform the agency’s decision on whether to pursue a competitive process. The government will not consider any unsolicited proposals received after the deadline and will not entertain inquiries via phone or email regarding this notice. All submissions must be sent via email to the specified address, and submitters assume full responsibility for timely delivery and completeness of information.
In-Vitro Diagnostic Substance Manufacturing

POSTED

6 days ago

DEADLINE

in 9 days
View Details
NAICS: 492110
Federal
RFI: Specialized Domestic and International Cold-Chain Logistics Services for the International Reagent Resource (IRR)The Centers for Disease Control and Prevention, through the National Center for Immunization and Respiratory Diseases, is seeking information from commercial logistics providers capable of supporting the domestic and international cold-chain distribution of diagnostic reagents, influenza viruses, molecular detection materials, and other temperature-sensitive biological products used for respiratory pathogen detection. These materials, handled and prepared at the American Type Culture Collection facility in Manassas, Virginia, require strict temperature controls—including refrigerated, frozen, and ultra-low temperature environments—as well as compliance with IATA, ICAO, DOT, and international regulatory standards. The logistics provider must ensure end-to-end chain-of-custody, real-time shipment tracking, validated packaging, and continuous cold-chain monitoring throughout transit, with the ability to respond to excursions and maintain product integrity under demanding conditions. The program also demands robust customs clearance support, import/export documentation assistance, dry ice replenishment during long-haul transit, and customer service available across multiple time zones to facilitate global delivery to public health labs, ministries of health, and research institutions. The request for information seeks detailed capabilities of vendors, including experience transporting biological and medical products, cold-chain infrastructure, temperature ranges supported, monitoring technologies, customs brokerage expertise, and international shipping reach, particularly in support of government and public health entities. Respondents must describe surge capacity for responding to seasonal influenza events or emerging disease outbreaks, quality management systems such as ISO or GDP compliance, IATA Dangerous Goods certifications, and performance metrics for on-time delivery and shipment integrity. The CDC is evaluating market readiness to inform future procurement requirements and is not soliciting bids or pricing at this stage. Responses must be submitted electronically in PDF format within ten pages, and must include both primary and secondary points of contact. The opportunity is open to all qualified providers, with no obligation to issue a contract, and submission is voluntary and at the respondent’s expense.
Couriers and Express Delivery Services

POSTED

7 days ago

DEADLINE

in 24 days
View Details
NAICS: 541715
Federal
Notice of Intent to Sole Source - Development and Validation of Diagnostic Methods for Coccidioidomycosis (Valley Fever)The Centers for Disease Control and Prevention intends to award a sole source firm fixed price contract to Valley Fever Solutions, INC, through the Valley Fever Center for Excellence at the University of Arizona, to develop, evaluate, and validate diagnostic methods for coccidioidomycosis, commonly known as Valley Fever. The project will utilize the center’s established biospecimen repository and clinical infrastructure to advance diagnostic assays, with additional specimen collection and enhanced storage capacity being implemented to meet expanded research demands. All work will be conducted exclusively at the Valley Fever Center for Excellence in Tucson, Arizona, with no performance occurring at CDC facilities. The contract is classified under Product or Service Code AN12 for Health R&D Services and NAICS Code 541715 for Research and Development in the Life Sciences, with a performance period spanning from September 30, 2026, to September 29, 2027. This procurement is being conducted under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1), allowing for non-competitive award due to the unique expertise and existing infrastructure of the Valley Fever Center for Excellence. Although this is a notice of intent for a sole source acquisition and not a competitive solicitation, interested parties may submit responses by 11:00 AM Eastern Time on July 29, 2026, to dwb7@cdc.gov. The government retains full discretion to determine whether competition will be pursued based on responses received. The contract is designated as a total small business set-aside, and all correspondence and submissions must be directed to the primary point of contact, Marquetta Taylor, at the CDC Office of Acquisition Services in Atlanta, Georgia.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

7 days ago

DEADLINE

in 7 days
View Details
NAICS: 813312
Federal
Non-Research Long-Term Care facility needed for the enrichment and socialization of Non-Human Primate colonyThe Centers for Disease Control and Prevention, through its Office of Acquisition Services, is seeking a qualified sanctuary to assume permanent ownership and long-term care of approximately 130 retired non-human primates, primarily rhesus and pigtailed macaques, no longer needed for federal research. The facility must be accredited by the Global Federation of Animal Sanctuaries and operate as a true sanctuary with no research, breeding, buying, selling, trading, or sale of animal byproducts, and must prohibit direct public contact. The contractor must provide naturalistic, GFAS-compliant enclosures and implement structured social group formation, behavioral rehabilitation, and lifelong veterinary and husbandry care for each animal, ensuring their physical and psychological well-being in perpetuity. All animals must remain at the facility unless transferred for critical health reasons, and the contractor must sterilize any unsterilized animals within six months of intake. The procurement is a firm-fixed-price contract with mandatory pass/fail screening for GFAS accreditation, after which offers are evaluated holistically based on facility design, staffing, animal management plans, past performance, and price, with technical and performance factors significantly outweighing cost. The contract requires submission of detailed transport, intake, and care plans, coordination with USDA-licensed transporters at the CDC Royal Campus in Atlanta, Georgia, and a final report documenting full integration of the animals. Payment terms are structured as monthly invoicing for transportation, food, and intake activities, with a lump-sum payment upon completion of all animal transfers. The contractor must comply with strict records management obligations under federal law, including NARA and Privacy Act requirements, and ensure all employees receive CDC-provided records training. Proposals must be submitted electronically by July 23, 2026, and must include proof of SAM registration, affirmative certifications regarding payments and confidentiality, and be organized into three volumes covering accreditation, facility and operational plans, and staffing with pricing. The contracting officer is Jennifer Gartzke, and all payments will be made via electronic funds transfer upon proper enrollment through SAM or the ACH Vendor Enrollment Form, with invoicing directed to the CDC Office of Financial Resources in Atlanta.
Environment, Conservation and Wildlife Organizations

POSTED

8 days ago

DEADLINE

in about 23 hours
View Details
NAICS: 541512
Federal
CDC Artificial Intelligence for Acquisition Support Reverse Industry DayThe Centers for Disease Control and Prevention’s Office of Acquisition Services is seeking information on commercially available Artificial Intelligence tools that can enhance federal acquisition processes across the entire lifecycle, including planning, market research, requirements development, solicitation, proposal evaluation, contract administration, and closeout. This initiative takes the form of a Reverse Industry Day, designed as a market research effort to expose government acquisition professionals to existing AI capabilities without implying any intent to procure. Selected vendors will be invited to present their tools in a virtual session lasting 45 minutes—30 minutes for demonstration and 15 minutes for Q&A—with attendance restricted to government acquisition staff. Presentations must focus on tools already in use by other agencies or commercial entities, clearly outlining how they address specific acquisition challenges; tools still in development should be noted accordingly. Vendors interested in participating must submit a two-page capability statement to Lauren Peel at ijt9@cdc.gov with the subject line formatted as 75D301-26-RFI-73483 [Vendor Name]. The response deadline for submissions is July 30, 2026, and any questions must be submitted by July 20, 2026, with answers potentially posted via amendment. The event is tentatively scheduled for August 2026, though no specific date has been confirmed. Participation does not guarantee future contracting opportunities, and vendors will be notified whether they have been selected to present. The effort is not subject to set-aside requirements and is administered by the CDC under the Department of Health and Human Services, with all correspondence directed through the specified point of contact in Atlanta, Georgia.
Computer Systems Design Services

POSTED

9 days ago

DEADLINE

in 8 days
View Details